Dextroamphetamine - Adverse effects
Research News and Information

Saturday, November 21, 2009

Sudden death and use of stimulant medications in youths.

13 Jun 2009 OBJECTIVE: The authors sought to determine whether a significant association exists between the use of stimulants and the rare event of sudden unexplained death in children and adolescents. METHOD: A matched case-control design was performed. ... Read more...

A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs.

29 Apr 2009 There is a need for novel anxiolytics, which are effective, but do not cause sedation, tolerance, and rebound anxiety on discontinuation. To investigate a procedure that can be used to assess these characteristics preclinically, rats were initially ... Read more...

Treatment for amphetamine withdrawal.

13 Apr 2009 BACKGROUND: Few studies examined treatments for amphetamine withdrawal, although it is a common problem among amphetamine users. Its symptoms, in particular intense craving, may be a critical factor leading to relapse to amphetamine use. In clinical ... Read more...

Latest indexed articles for 'Dextroamphetamine - Adverse effects'

These are the very latest articles for this heading:

• Sudden death and use of stimulant medications in youths. 13 Jun 2009
• A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs. 29 Apr 2009
• Treatment for amphetamine withdrawal. 13 Apr 2009
• Abuse liability and safety of oral lisdexamfetamine dimesylate in individuals with a history of stimulant abuse. 25 Mar 2009
• MDMA reinstates cocaine-seeking behaviour in mice. 30 Jan 2009
• 'Kiddie drugs' and controlled pleasure: recreational use of dexamphetamine in a social network of young Australians. 22 Jan 2009
• [Driving under the influence of amphetamine and metamphetamine] 13 Jan 2009
• The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults. 30 Dec 2008
• Combined effects of acute stress and amphetamine on serial memory retrieval pattern in mice. 2 Dec 2008
• Stimulant treatment of frontotemporal dementia in 8 patients. 29 Nov 2008
• Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy. 13 Oct 2008
• A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. 12 Sep 2008
• Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. 7 Sep 2008
• Lisdexamfetamine: a prodrug stimulant for ADHD. 30 Jul 2008
• Human pharmacology of intravenous lisdexamfetamine dimesylate: abuse liability in adult stimulant abusers. 15 Jul 2008
• Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. 29 Jun 2008
• Poison centers detect an unexpectedly frequent number of adverse drug reactions to lisdexamfetamine. 29 Jun 2008
• Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44 h of continuous wakefulness. 31 May 2008
• Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder. 30 May 2008
• Lisdexamfetamine dimesylate for childhood ADHD. 29 Apr 2008

See a longer list of these articles.

Technical information about 'Dextroamphetamine'

Definition: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.

Chemical name: Benzeneethanamine, alpha-methyl-, (S)-

Registry Number: 51-64-9

Descriptor UI: D003913

Alternative terms: Dextroamphetamine; dextro-Amphetamine; dextro Amphetamine; Dexamphetamine; d-Amphetamine; d Amphetamine; Dexamfetamine; Oxydess; Vortech Brand of Dextroamphetamine Sulfate; Dextroamphetamine Sulfate; Sulfate, Dextroamphetamine; d-Amphetamine Sulfate; d Amphetamine Sulfate; Dextro-Amphetamine Sulfate; Dextro Amphetamine Sulfate; DextroStat; Shire Brand of Dextroamphetamine Sulfate; Curban; Pasadena Brand of Dextroamphetamine; Dexedrine; GlaxoSmithKline Brand of Dextroamphetamine Sulfate; Mallinckrodt Brand of Dextroamphetamine Sulfate; Celltech Brand of Dextroamphetamine Sulfate;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Dopamine Uptake Inhibitors; Central Nervous System Stimulants;

Tree Number: D02.092.471.683.152.110.200;

Online Note: use DEXTROAMPHETAMINE to search DEXTRO AMPHETAMINE 1966-76

History Note: 77; was DEXTRO AMPHETAMINE 1963-76